Suneva Medical, Inc. is a privately held medical technology company focused on developing, manufacturing and commercializing novel, differentiated aesthetic products for the dermatology, plastic and cosmetic surgery markets.

	Suneva Medical Selects Quinnova Pharmaceuticals to Co-promote Refissa® - Topical Rx Skin Care Treatment Suneva Medical Announces Results of Its Pivotal ArteFill® Acne Scar Study Obagi Medical Products and Suneva Medical Partner to Offer ReGenica® Facial Rejuvenation Complex Suneva Medical Completes Enrollment and Initial Treatment of Patients in Phase III Acne Scar Study Suneva Medical Introduces ReGenica™, the Next Generation of Growth Factor Skincare Suneva Medical Acquires Product Portfolio from Spear Pharmaceuticals - Refissa Leads Suneva into the Topical Aesthetic Market Histogen Signs License Agreement with Suneva Medical for Cell Conditioned Media-based Aesthetic Products Suneva Medical to Pursue Expanded Indications for Artefill® with Launch of Phase III Acne Scar Study   Artefill® Recently Featured on "The Doctors" TV Show Leading U.S. Dermatologist Reports Positive Data on Artefill®